Skip to main content
. 2019 Oct 1;10:1235. doi: 10.3389/fphys.2019.01235

FIGURE 4.

FIGURE 4

Corticosteroids treatment did not affect the release of PGE2 from exacerbated COPD-derived PBMCs. Exacerbated COPD-derived PBMCs were stimulated with Dexamethasone (DEX, 0.1 ng/ml and 1 ng/ml) (A) and Indomethacin (Indo, 3.5 μg/ml) (B) Poly dA:dT (1 μg/ml), and PGE2 levels were evaluated. Data are represented as median ± interquartile range (n = 4). Statistically significant differences were determined by ONE-way ANOVA followed by Dunn’s post–test.